Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines

David S. Ettinger; Douglas E. Wood; Dara L. Aisner; Wallace Akerley; Jessica R. Bauman; Ankit Bharat; Debora S. Bruno; Joe Y. Chang; Lucian R. Chirieac; Thomas A. D'Amico; Thomas J. Dilling; Jonathan Dowell; Scott Gettinger; Matthew A. Gubens; Aparna Hegde; Mark Hennon; Rudy P. Lackner; Michael Lanuti; Ticiana A. Leal; Jules Lin; Billy W. Loo; Christine M. Lovly; Renato G. Martins; Erminia Massarelli; Daniel Morgensztern; Thomas Ng; Gregory A. Otterson; Sandip P. Patel; Gregory J. Riely; Steven E. Schild; Theresa A. Shapiro; Aditi P. Singh; James Stevenson; Alda Tam; Jane Yanagawa; Stephen C. Yang; Kristina M. Gregory; Miranda Hughes

Article

Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines

JNCCN Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2021.0013

863Citations

207Readers

Get full text

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

Cite

CITATION STYLE

APA

Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., … Hughes, M. (2021, March 1). Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network. Harborside Press. https://doi.org/10.6004/jnccn.2021.0013

Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines

Abstract

Cite

Register to see more suggestions